Author

Roman A. Ivanov

Sirius University of Science and TechnologyORCID 0000-0002-9573-4183Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Anastasia N. Zolotar· 2 shared Andrei E. SiniaviniD· 2 shared Denis A. KleymenoviD· 2 shared Denis Y. LogunoviD· 2 shared Elena P. MazuninaiD· 2 shared Elena V. ShidlovskayaiD· 2 shared Evgeniia N. BykoniaiD· 2 shared Evgeny V. UsacheviD· 2 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Anastasia N. Zolotar

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyFrontiers in ImmunologyPeer-reviewedApr 16, 2024

Trivalent mRNA vaccine-candidate against seasonal flu with cross-specific humoral immune response

Elena P. Mazunina, Vladimir А. Gushchin, Denis A. Kleymenov…·Gintsburg Al

This study develops a trivalent mRNA vaccine candidate for seasonal flu, showing higher immunogenicity and cross-specific humoral immune response compared to an inactivated split vaccine.

24 citationstop 2%

experimental assaydrug response / drug discovery

𝕏 PostBluesky

ImmunologyVaccinesPeer-reviewedApr 2, 2024

Major role of S-glycoprotein in providing immunogenicity and protective immunity in mRNA lipid nanoparticle vaccines based on SARS-CoV-2 structural proteins

Evgeniia N. Bykonia, Denis A. Kleymenov, Vladimir А. Gushchin…·Gintsburg Al

This study evaluates mRNA-LNP vaccines encoding SARS-CoV-2 structural proteins, finding that the S protein enhances immune responses to N protein, while M protein has low immunogenicity.

4 citations

mousebulk RNA-seq

𝕏 PostBluesky